Ops can cripple even high-falutin trials; Europe seeks project proposals;

> In particle-accelerator development and drug development alike, advanced science and sophisticated experimental design do not inoculate studies against operational issues. Article

> The Innovative Medicines Initiative, a European government/industry partnership, has launched its second call for proposals, inviting research consortia to submit their ideas for projects on nine scientific topics. Article

> Millipore has implemented Thermo Fisher Scientific's Watson lab information management system for its preclinical and clinical development services group. Release

> A service for the delivery of novel lead candidates in the form of a rich data set and high quality compound samples is being offered by InhibOx in the UK and MolPort of Latvia. Announcement

> The VaryScreen ADME-Tox workstation from Hudson Robotics provides automated profiling of the absorption, distribution, metabolism and excretion properties of drug molecules. Release

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.